Related Experiment Video
Updated: Jul 21, 2025

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Chitosan/Virgin-Coconut-Oil-Based System Enriched with Cubosomes: A 3D Drug-Delivery Approach
Simone S Silva1,2, Luísa C Rodrigues1,2, Emanuel M Fernandes1,2
13B's Research Group-Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal.
Researchers developed porous biomaterials using chitosan and virgin coconut oil for drug delivery. These scaffolds sustained the release of anti-inflammatory drugs, offering a sustainable pathway for biomedical applications.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Natural polymers and vegetable oils offer potential for biomedical applications.
- Chitosan (CHT) and virgin coconut oil (VCO) were combined to create an emulsion system.
- Phytantriol-based cubosomes encapsulating sodium diclofenac were incorporated for drug delivery.
Purpose of the Study:
- To develop novel porous biomaterials for drug delivery.
- To investigate the properties of CHT/VCO-based emulsion scaffolds.
- To evaluate the drug release profile of sodium diclofenac from the developed system.
Main Methods:
- Formation of CHT/VCO emulsion.
- Encapsulation of sodium diclofenac within phytantriol-based cubosomes.
- Dispersion of cubosomes into the CHT/VCO emulsion.
- Freeze-drying to create porous scaffolds.
- Characterization of scaffold porosity, swelling, and stiffness.
- In vitro drug release studies in PBS.
Main Results:
- Scaffolds exhibited a porous structure (20.4–73.4 µm) and high swelling ability (up to 900% in PBS).
- The presence of cubosomes enhanced scaffold stiffness.
- Sustained release of sodium diclofenac was observed (45 ± 2% accumulated release), significantly lower than free diclofenac (80 ± 4%).
Conclusions:
- The developed CHT/VCO-based emulsion scaffolds are promising porous biomaterials for drug delivery.
- The system demonstrates controlled and sustained release of anti-inflammatory drugs.
- This approach provides a sustainable pathway for designing advanced drug delivery systems.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
COP Coated Vesicles

